UK: Warner-Lambert Co LLC v. Actavis Group PTC, High Court of England and Wales, Chancery Division, Patents Court, HP-2014-000035 HP-2014-000021 HP-2014-001795, 10 September 2015

The U.K. Patents Court has held Warner-Lambert's second medical use patent regarding the use of pregabalin for the treatment of pain invalid on the ground of insufficiency. Even if the patent were valid, the Court held that Actavis would not have infringed Warner-Lambert's patent as a result of any "cross-label" use of their product sold on a skinny label.

A full summary of this case has been published on Kluwer IP Law.